![]() |
|
|

Department of Food Science, Swedish University of Agricultural Sciences, Uppsala, Sweden,
* Department of Public Health and Clinical Medicine/Nutritional Research, University of Umeå, Umeå, Sweden and
Department of Medical Biosciences/Pathology, University of Umeå, Umeå, Sweden
2To whom correspondence should be addressed. E-mail: Alastair.Ross{at}lmv.slu.se.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: alkylresorcinols biomarker human ileostomists rye bread whole grain cereals
Many epidemiological studies have linked the consumption of diets rich in whole grain cereals to a decreased incidence of several degenerative "Western" diseases (13). The FDA has approved health claims stating that whole grain cereals may protect against coronary heart disease and some cancers (4). A direct link between consumption of whole grain cereals and the proposed health effects has not been established, in part because of the lack of a suitable biomarker of whole grain cereal intake (5).
Whole grain cereals are high in dietary fiber, vitamins and minerals, and many phenolic antioxidants thought to be beneficial to health (6). These are largely lost on removing the outer layers of cereals when milling (7). Alkylresorcinols (AR) are phenolic lipids located in the outer part of some whole grain cereals, and found in particularly high amounts in wheat, triticale and rye grains (8). AR are 1,3-dihydroxybenzene compounds with an alkyl chain substituted at position 5 of the phenolic ring. Nomenclature refers to the length of the carbon chain; for example, nonadecylresorcinol, an AR with a saturated 19-carbon chain, is referred to as C19:0. Concentrations in whole grain rye and wheat have been found to vary between 360 and 3200 µg/g and 317 and 1429 µg/g, respectively (9 and references therein). AR are also found in some other plants, bacteria and fungi (10), although not in significant levels in any food plants other than wheat and rye (9). Unsaturated and oxygenated analogs of AR have also been reported in rye (11), although AR are the predominant phenolic lipids in rye (
8085%) and wheat (
95%) (9,12). Processing, such as baking or heating does not appear to affect the levels of AR in food products (9). A person eating a diet rich in whole grain wheat and rye is estimated to have an intake of 100200 mg/d (Ross, A. B. et al., unpublished results).
AR are reported to be antioxidants (10), although their activity is negligible in in vitro model systems when compared with
-tocopherol (13). AR have also been shown to have anticancer activity, to modify the structure and function of phospholipid membranes in vitro and to inhibit some enzymes, as comprehensively reviewed by Kozubek and Tyman (10). Despite extensive research on the biochemical effects of AR, their uptake and metabolism in animals and humans are essentially unknown (10). AR have been proposed as antinutritional factors in rye (14), although rat studies are inconclusive (15,16). The soluble fiber fraction of rye is now considered to cause the antinutritional effect originally attributed to AR (17).
Ileal digestibility of AR in pigs was found to be between 60 and 79%, and rats fed radiolabeled AR excreted
34% of the radioactivity in the urine, showing that significant amounts of AR had been absorbed and metabolized (Ross, A. B. et al., unpublished results). AR were also found in intact form in human plasma (18), indicating that they are absorbed, although to what extent is not known. In this study, we used an ileostomy model to demonstrate that AR disappear from the small intestine of humans, suggesting that AR are absorbed.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
Ten subjects volunteered to participate in the study (2 females, age 34 and 51 y; 8 males, mean age 54.4 y, range 4365 y). All subjects had undergone proctocolectomy 829 y earlier as a result of ulcerative colitis and had conventional ileostomies that functioned well with no sign of inflammation. All subjects were in good general health on the basis of physical examination and blood tests before the experiment. The study was approved by the Ethical Committee of the Umeå University Hospital. For further details regarding the subjects, diets and study design see Lundin et al. (19).
Study design and diets.
The subjects were studied for a total of 5 wk (consecutive) on an outpatient basis. Subjects were randomly arranged into two experimental groups, with five in each group. Two crossover studies were carried out, with two diets, and two meal frequencies (nibbling and ordinary) per diet. All subjects ate both diets, with both meal frequencies. Both of the experimental groups started a low fiber diet (LFD, AR free) for 2 wk in which one group was given the nibbling meal frequency for 1 wk and the other group the ordinary meal frequency for 1 wk. In the following week, those on the nibbling meal frequency switched to the ordinary meal frequency and vice versa. After 2 wk, a 1-wk washout period was used when the subjects ate their ordinary diet. This was followed by a high fiber diet (HFD, AR rich) period for 2 wk with the same crossover design of ordinary and nibbling meal frequencies as for the LFD. During the nibbling meal frequency, the subjects ate seven identical meals/d, whereas during the ordinary meal frequency they consumed the same diet divided into three meals/d; one seventh of the daily diet for breakfast, two sevenths for lunch and four sevenths for dinner. Based on a 3-d dietary recall according to the recommendation of FAO/WHO/UNU (20), the subjects were arranged in three energy levels corresponding to 1.0, 1.25 or 1.5 portions of the diets.
During the LFD period a 1.0 energy level dietary portion of the breads consisted of white wheat flour soft bread (142.8 g/24 h) and white wheat flour crispbread (Wasavete, Wasabröd AB, Filipstad, Sweden; 92.4 g/24 h), whereas during the HFD period, the breads consisted of rye branenriched soft bread (180.6 g/24 h) and whole grain rye crisp bread (Husman, Wasabröd AB; 91.0 g/24 h). One piece of wheat flour soft bread contained 37 g of wheat flour, 4 g margarine, 4 g sugar, 4 g low fat milk powder and 2 g yeast. One piece of rye bran soft bread contained 15 g wheat flour, 18 g rye bran, 3 g margarine, 3 g sugar, 2 g low fat milk powder and 2 g yeast. The amount of dietary fiber per piece of bread was 1.5 g in white wheat flourbased soft bead (61.1 g), 0.5 g in Wasavete (13.2 g), 5.4 g in rye branbased soft bread (51.5 g) and 1.7 g dietary fiber in Husman (13.0 g). The rye breads used in the study were the only source of AR in the diet. The Swedish Food Tables (21) were used to calculate energy and nutrient contents of the diets.
On d 3 in each dietary period, 24-h ileal effluents were collected. On that day the subjects were admitted to the research ward and stayed in a nearby hotel overnight. The ileostomy effluent bags were changed every 2 h from 0700 to 2100 h on the sampling day and at 0700 h on the next day (19). The bags were immediately frozen, and the effluents were freeze-dried to constant weight, mixed, homogenized and stored at -70°C until analysis. Two portions of the bread were collected on the sampling day and treated the same way as the ileostomy effluents.
Analysis.
Before analysis, samples were ground in a Cyclotec sample mill (Tecator AB, Höganäs, Sweden) to pass a 0.5-mm screen. Dry matter content was determined by oven drying at 105°C for 16 h. Bread samples were analyzed for AR according to Ross et al. (9). Full-recovery AR in ileostomy samples was possible by use of the same extraction method as for whole grain rye (12), the complexes formed during baking being broken down in the gastrointestinal tract. Quantification of total and individual AR homologs was performed by gas chromatography (12). The presence of AR in rye ileostomy extracts was confirmed by use of gas chromatographymass spectrometry according to Ross and colleagues (Ross, A. B. et al., unpublished results) (Fig. 1). Results are reported on a dry matter basis and as an average of triplicate analyses (any sample with a CV > 5% was repeated).
|
| RESULTS |
|---|
|
|
|---|
600 µg AR/g dry matter.
The total recoveries of AR from the small intestine during the HFD dietary period were 42%, and 43% for the nibbling and ordinary dietary meal frequencies, respectively, indicating an ileal digestibility of
60% (Table 1). In this study, no difference in ileal disappearance of AR was observed between subjects eating 1 portion (147 mg AR/d) or 1.5 portions of experimental diet (220 mg AR/d). There was large individual variation for ileal digestibility (range 4571%).
|
59% ileal digestibility), but the ileal digestibility of C23:0 and C25:0 was significantly lower (
47%; P < 0.001) for the ordinary meal frequency (Table 1). | DISCUSSION |
|---|
|
|
|---|
The amount of dietary AR has been suggested to affect their absorption, with decreased uptake at higher levels of intake (Ross, A. B. et al., unpublished results; 22). In this study, meal frequency had no apparent impact on AR absorption, although there was a slight difference in the uptake of the longer-chain AR homologs (C23:0 and C25:0) between the nibbling and ordinary meal frequencies. Chain length has an effect on uptake of triacylglycerols, with medium-chain fatty acids being taken up at a greater rate than long-chain fatty acids (23), and this may also be the case for AR.
AR are present in high levels in whole grain wheat and rye (0.050.1%). The facts that they are present only in products containing whole grain, coarse flour or bran fractions of wheat and rye, are stable during food processing (9) and are absorbed by humans suggest that they might be potential biomarkers of whole grain wheat and rye intake. For these reasons, AR have an advantage over enterolactone, a metabolite of plant lignans that was previously suggested as a biomarker of whole grain intake (24,25). Although serum enterolactone is elevated by consumption of whole grain cereals (26), it is not specific because it is also elevated by other plant foods as well as coffee and alcoholic beverages (27). Rats fed radiolabeled C21:0 cleared most of a single dose by 60 h (Ross, A. B. et al., unpublished results). If this is also the case for humans, it may limit the usefulness of AR as biomarkers. Before establishing this possibility, more detailed studies are needed to explore whether there is a correlation between whole grain wheat and rye intake and amounts in plasma and/or urine. Because AR have been shown to be absorbed by rats, pigs and humans, it is strongly warranted in further research to investigate their metabolism, biokinetics, biological activities and use as biomarkers of whole grain wheat and rye intake.
| FOOTNOTES |
|---|
3 Abbreviations used: AR, alkylresorcinol(s); HFD, high fiber diet; IS, internal standard; LFD, low fiber diet; SIR, single ion recording. ![]()
Manuscript received 31 March 2003. Initial review completed 7 April 2003. Revision accepted 22 April 2003.
| LITERATURE CITED |
|---|
|
|
|---|
1. Truswell, A. S. (2002) Cereal grains and coronary heart disease. Eur. J. Clin. Nutr. 56:1-14.[Medline]
2. Levi, F., Pasche, C., Lucchini, F., Chatenoud, L., Jacobs, D. R., Jr & La Vecchia, C. (2000) Refined and whole grain cereals and the risk of oral, oesophageal and laryngeal cancer. Eur. J. Clin. Nutr. 54:487-489.[Medline]
3. Slavin, J. L., Jacobs, D., Marquart, L. & Wiemer, K. (2001a) The role of whole grains in disease prevention. J. Am. Diet. Assoc. 101:780-785.[Medline]
4. Kantor, L. S., Variyam, J. N., Allshouse, J. E., Putnam, J. J. & Lin, B.-H. (2001) Choose a variety of grains daily, especially whole grains: a challenge for consumers. J. Nutr. 131:473S-486S.
5. Branca, F., Hanley, A. B., Pool-Zobel, B. & Verhagen, H. (2001) Biomarkers in disease and health. Br. J. Nutr. 86:S55-S92.
6. Slavin, J. L., Martini, M., Jacobs, D. R., Jr & Marquart, L. (1999) Plausible mechanisms for the protectiveness of whole grains. Am. J. Clin. Nutr. 70(suppl.):459S-463S.
7. Slavin, J. L., Jacobs, D. & Marquart, L. (2001b) Grain processing and nutrition. Crit. Rev. Biotechnol. 21:49-66.[Medline]
8. Gohil, S., Pettersson, D., Salomonsson, A.-C. & Åman, P. (1988) Analysis of alkyl- and alkenylresorcinols in triticale, wheat and rye. J. Sci. Food Agric. 45:43-52.
9. Ross, A. B., Shepherd, M. J., Schüpphaus, M., Sinclair, V., Alfaro, B., Kamal-Eldin, A. & Åman, P. (2003) Alkylresorcinols in cereals and cereal products. J. Agric. Food Chem. in press.
10. Kozubek, A. & Tyman, J.H.P. (1999) Resorcinolic lipids, the natural non-isoprenoid phenolic amphiphiles and their biological activity. Chem. Rev. 99:1-25.[Medline]
11. Seitz, L. (1992) Identification of 5-(2-oxoalkyl)-resorcinols and 5-(2-oxoalkenyl)-resorcinols in wheat and rye grains. J. Agric. Food Chem. 40:1541-1546.
12. Ross, A. B., Kamal-Eldin, A., Jung, C., Shepherd, M. J. & Åman, P. (2001) Gas chromatographic analysis of alkylresorcinols in rye grains (Secale cereale L.). J. Sci. Food Agric. 81:1405-1411.
13. Kamal-Eldin, A., Pouru, A., Eliasson, C. & Åman, P. (2001) Alkylresorcinols as antioxidants: hydrogen donation and peroxyl radical-scavenging effects. J. Sci. Food Agric. 81:353-356.
14. Wieringa, G. W. (1967) On the Occurrence of Growth Inhibiting Substances in Rye (Publication No. 156) 1967 Institute of Storage and Processing of Agricultural Produce Wageningen, The Netherlands.
15. Bock, H.-D., Flamme, W. & Kesting, S. (1981) Orientierende Versuche an Ratten über Alkylresorcinole in Roggen (Preliminary experiments with rats on alkylresorcinols in rye). Nahrung 25:805-810.[Medline]
16. Sedlet, K., Mathias, M. & Lorenz, K. (1984) Growth-depressing effects of 5-n-pentadecylresorcinol: a model for cereal alkylresorcinols. Cereal Chem. 61:239-241.
17. Vinkx, C.J.A. & Delcour, J. A. (1996) Rye (Secale cereale L.) arabinoxylans: a critical review. J. Cereal Sci. 24:1-14.
18. Linko, A.-M., Parikka, K., Wähälä, K. & Adlercreutz, H. (2002) Gas chromatographic-mass spectrometric method for the determination of alkylresorcinols in human plasma. Anal. Biochem. 308:307-313.[Medline]
19. Lundin, E., Zhang, J.-X., Lairon, D., Tidehag, P., Åman, P., Adlercreutz, H. & Hallmans, G. (2001) Effects of meal frequency and rye bran on glucose and lipid metabolism and ileal excretion of energy and sterols in ileostomy subjects. Dean of the Faculty of Medicine, eds. The Dietary Fiber Complex, Intestinal Function and Metabolic Effects. Experimental and Epidemiology Studies 2001 Umeå University Medical Dissertation Umeå, Sweden. .
20. FAO/WHO/UNU (1985) Energy and protein requirements. WHO Tech. Rep. Ser. 724:52-71.
21. Food Composition Tables Second edition 1986 (revised 1988) 1988 Swedish National Food Administration Uppsala, Sweden .
22. T
u
cik, F., Kupiec, R. & Rakowska, M. (1990) Studies on antinutritive components of the rye grain. II. Balance and metabolism of 5-n-alkylresorcinols in rats. Acta Aliment. Polon. 16:119-128.
23. Ramírez, M., Amate, L. & Gil, A. (2001) Absorption and distribution of dietary fatty acids from different sources. Early Hum. Dev. 65:S95-S101.
24. Stumpf, K., Pietinen, P., Puska, P. & Adlercreutz, H. (2000) Changes in serum enterolactone, genistein, and daidzein in a dietary intervention study in Finland. Cancer Epidemiol. Biomarkers Prev. 9:1369-1372.
25. Lampe, J. W. (2003) Isoflavonoid and lignan phytoesterogens as dietary biomarkers. J. Nutr. 133:956S-964S.
26. Jacobs, D. R., Jr, Pereira, M. A., Stumpf, K., Pins, J. J. & Adlercreutz, H. (2002) Whole grain food intake elevates serum enterolactone. Br. J. Nutr. 88:111-116.[Medline]
27. Horner, N. K., Kristal, A. R., Prunty, J., Skor, H. E., Potter, J. D. & Lampe, J. W. (2002) Dietary determinants of plasma enterolactone. Cancer Epidemiol. Biomarkers Prev. 11:121-126.
This article has been cited by other articles:
![]() |
R. M van Dam and F. B Hu Are alkylresorcinols accurate biomarkers for whole grain intake? Am. J. Clinical Nutrition, April 1, 2008; 87(4): 797 - 798. [Full Text] [PDF] |
||||
![]() |
R. Landberg, A. Kamal-Eldin, A. Andersson, B. Vessby, and P. Aman Alkylresorcinols as biomarkers of whole-grain wheat and rye intake: plasma concentration and intake estimated from dietary records Am. J. Clinical Nutrition, April 1, 2008; 87(4): 832 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Linko-Parvinen, R. Landberg, M. J. Tikkanen, H. Adlercreutz, and J. L. Penalvo Alkylresorcinols from Whole-Grain Wheat and Rye Are Transported in Human Plasma Lipoproteins J. Nutr., May 1, 2007; 137(5): 1137 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Landberg, A.-M. Linko, A. Kamal-Eldin, B. Vessby, H. Adlercreutz, and P. Aman Human Plasma Kinetics and Relative Bioavailability of Alkylresorcinols after Intake of Rye Bran J. Nutr., November 1, 2006; 136(11): 2760 - 2765. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Linko, K. S. Juntunen, H. M. Mykkanen, and H. Adlercreutz Whole-Grain Rye Bread Consumption by Women Correlates with Plasma Alkylresorcinols and Increases Their Concentration Compared with Low-Fiber Wheat Bread J. Nutr., March 1, 2005; 135(3): 580 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Ross, Y. Chen, J. Frank, J. E. Swanson, R. S. Parker, A. Kozubek, T. Lundh, B. Vessby, P. Aman, and A. Kamal-Eldin Cereal Alkylresorcinols Elevate {gamma}-Tocopherol Levels in Rats and Inhibit {gamma}-Tocopherol Metabolism In Vitro J. Nutr., March 1, 2004; 134(3): 506 - 510. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||